Licensee Discretion and CNI Digital Channel Preemption Sample Clauses

Licensee Discretion and CNI Digital Channel Preemption. CNI recognizes that the Licensee of the Station has full authority to control the Station under currently applicable law. The Station agrees that, should the law or FCC rules, policies or interpretations change to permit users of digital broadcast spectrum to control directly their own use of the spectrum, this subsection shall no longer apply. Until such change, however, the following provisions shall apply to the minimum extent required by the FCC (if at all), the parties intending that CNI would have absolute control of the CNI Digital Channel under this Agreement if and to the extent permitted by law. The Licensee of the Station shall have the right to reject any portion of the CNI 24-hour Digital Programming to be broadcast on the Station which the Licensee reasonably believes to be an Unsuitable Program. In the event of any such rejection by the Licensee, the Licensee shall give CNI written notice of such rejection at least 7 days in advance of the scheduled broadcast or as soon as possible. Any portion of the CNI 24-hour Digital Programming may be deemed by the Licensee to be an Unsuitable Program only if: (i) the Licensee reasonably believes that the telecast of such CNI Programming from the CNI 24-hour Digital Programming would violate applicable governmental laws, rules, regulations or published policies or (ii) if in the Licensee’s reasonable judgment preemption of such CNI Programming from the CNI 24-hour Digital Programming is required in order for the Station to meet the public interest programming obligations imposed by the FCC that cannot otherwise be met by the Station and the Licensee provides a written explanation for its determination. No CNI 24-hour Digital Programming may be deemed by Licensee to be an Unsuitable Program based on program performance or ratings, advertiser reactions or the availability of alternate programming which the Licensee believes to be more profitable or attractive than such CNI 24-hour Digital Programming. If the Licensee refuses to broadcast any Unsuitable Program, CNI shall have the right to provide substitute CNI Programming to the Station from the previously approved CNI Programming. The Licensee may also preempt the CNI 24-hour Digital Programming to provide the broadcast of live reports of a fast breaking news event free of commercial announcements or any promotional announcements for the Station or its network.
Sample 1
AutoNDA by SimpleDocs

Related to Licensee Discretion and CNI Digital Channel Preemption

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • License; Use Upon delivery to an Authorized Person or a person reasonably believed by Custodian to be an Authorized Person of the Fund of software enabling the Fund to obtain access to the System (the “Software”), Custodian grants to the Fund a personal, nontransferable and nonexclusive license to use the Software solely for the purpose of transmitting Written Instructions, receiving reports, making inquiries or otherwise communicating with Custodian in connection with the Account(s). The Fund shall use the Software solely for its own internal and proper business purposes and not in the operation of a service bureau. Except as set forth herein, no license or right of any kind is granted to the Fund with respect to the Software. The Fund acknowledges that Custodian and its suppliers retain and have title and exclusive proprietary rights to the Software, including any trade secrets or other ideas, concepts, know-how, methodologies, or information incorporated therein and the exclusive rights to any copyrights, trademarks and patents (including registrations and applications for registration of either), or other statutory or legal protections available in respect thereof. The Fund further acknowledges that all or a part of the Software may be copyrighted or trademarked (or a registration or claim made therefor) by Custodian or its suppliers. The Fund shall not take any action with respect tot the Software inconsistent with the foregoing acknowledgement, nor shall the Fund attempt to decompile, reverse engineer or modify the Software. The Fund may not xxx, sell, lease or provide, directly or indirectly, any of the Software of any portion thereof to any other person or entity without Custodian’s prior written consent. The Fund may not remove any statutory copyright notice or other notice included in the Software or on any media containing the Software. The Fund shall reproduce any such notice on any reproduction of the Software and shall add any statutory copyright notice or other notice to the Software or media upon Custodian’s request.

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • WHEXXXX xs xxxx of a plan of reorganization, RESTART PARTNERS, L.P., a Delaware Limited Partnership ("Restart"), may acquire an ownership interest in Elsinore Corporation ("Elsinore") or the Four Queens, Inc. ("FQI");

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensee Licensee represents and warrants that:

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

Time is Money Join Law Insider Premium to draft better contracts faster.